Vanda Gains Branded Successor To Fanapt As US FDA Approves Another Antipsychotic

Mental Health Disorder
Bipolar I disorder affects a large share of the nearly 10 million Americans with bipolar disorder, while schizophrenia impacts about 1% of U.S. adults, or roughly 2.8 million people. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business